Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 4/20 | 0.45 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ABAT | P80404 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL63724 | 0.89 | IDO1 (0.56) | IDO1ESR1CALM1ESR2MEN1 | |
| SCHEMBL26264321 | 0.82 | ESR2 (0.54) | IDO1ESR1CALM1ESR2MEN1 | |
| Methyl Alcohol SCHEMBL28236652 | 0.78 | IDO1 (0.42) | IDO1CALM1APPLMNATP53 | |
| SCHEMBL134443 | 0.78 | IDO1 (0.46) | IDO1APPLMNATP53ERN1 | |
| SCHEMBL27881161 | 0.77 | APP (0.66) | CALM1MEN1KMT2AAPPLMNA | |
| SCHEMBL9856466 | 0.77 | APP (0.54) | ESR1MEN1KMT2AAPPCA2 | |
| SCHEMBL28143197 | 0.77 | APP (0.66) | CALM1MEN1KMT2AAPPLMNA | |
| SCHEMBL9856469 | 0.77 | APP (0.54) | ESR1MEN1KMT2AAPPCA2 | |
| Oxirane SCHEMBL4884714 | 0.77 | ESR1 (0.74) | IDO1ESR1ESR2MEN1KMT2A | |
| Hydroquinone SCHEMBL2867425 | 0.75 | ALOX15 (0.61) | ESR1ESR2MEN1KMT2ACA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2129758-A2 | PERFUME COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-12-09 | — | — | EP | claimed |
| WO-2008104352-A2 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-09-04 | — | — | WO | claimed |
| US-9585826-B2 | Triggerable compositions for two-stage, controlled release of active chemistry | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2017-03-07 | — | — | US | disclosed |
| US-20140128827-A1 | TRIGGERABLE COMPOSITIONS FOR TWO-STAGE, CONTROLLED RELEASE OF ACTIVE CHEMISTRY | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2014-05-08 | — | — | US | disclosed |
| EP-2129758-A2 | PERFUME COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008104352-A2 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128827-A1 | TRIGGERABLE COMPOSITIONS FOR TWO-STAGE, CONTROLLED RELEASE OF ACTIVE CHEMISTRY | BCHE, CEL, ACHE | IDO1 701/4885ESR1 1869/4885CALM1 2119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.